February 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Lina Elfaki: Anticoagulation Medications – A Critical Component of Patient Safety

Lina Elfaki/LinkedIn

Dec 25, 2025, 03:33

Lina Elfaki: Anticoagulation Medications – A Critical Component of Patient Safety

Lina Elfaki, Senior clinical pharmacist, shared on LinkedIn:

“Anticoagulation Medications: A Critical Component of Patient Safety
Anticoagulation therapy plays a vital role in preventing and managing thromboembolic disorders across medical and surgical settings. From atrial fibrillation to post-operative care, the safe and effective use of anticoagulants requires careful clinical judgment and monitoring.

Key Anticoagulation Medications:

• Heparin & Low-Molecular-Weight Heparins (Enoxaparin)
• Vitamin K Antagonists (Warfarin)
• Direct Oral Anticoagulants (DOACs): Apixaban, Rivaroxaban, Dabigatran, Edoxaban

Clinical Focus Areas:

• Individualized dosing based on renal function and patient risk
• Monitoring for bleeding and thrombotic complications
• Managing drug–drug and drug–food interactions
• Peri-operative anticoagulation planning
• Patient education to ensure adherence and safety

Interdisciplinary collaboration—especially involving clinical pharmacists—enhances therapeutic outcomes and minimizes preventable adverse events.”

Lina Elfaki: Anticoagulation Medications - A Critical Component of Patient Safety